GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,308.50p
   
  • Change Today:
      8.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,300.00p
  • Currency: UK Pounds
  • Shares Issued: 4,145.10m
  • Volume: 3,969,966
  • Market Cap: £54,239m
  • RiskGrade: 129
  • Beta: 0.56

Newspaper Links

GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph
Ebola vaccine trials 'encouraging', says GSK 27-Nov-2014 Telegraph
GlaxoSmithKline tops table in effort to get drug... 17-Nov-2014 Guardian
GlaxoSmithKline's mulled HIV spin-off 'bigger th... 23-Oct-2014 Telegraph
GlaxoSmithKline shares rise after drugs giant pl... 23-Oct-2014 Daily Mail
Glaxo to float its HIV cures as a standalone £15... 23-Oct-2014 The Independent
RBS chairman to head embattled GlaxoSmithKline 26-Sep-2014 Guardian
Royal Bank of Scotland chairman to move to Glaxo... 25-Sep-2014 Guardian
GSK to start production of Ebola vaccine as test... 29-Aug-2014 Guardian
MARKET REPORT: Evotec deal just the tonic for Gl... 28-Aug-2014 Express & Star
GlaxoSmithKline faces fresh drug bribery claims ... 13-Aug-2014 Guardian
Now GlaxoSmithKline faces claims of bribery from... 13-Aug-2014 Daily Mail
GlaxoSmithKline faces fresh bribery allegations ... 13-Aug-2014 The Independent
Peter Humphrey trial: GlaxoSmithKline to blame, ... 08-Aug-2014 Telegraph
GlaxoSmithKline looking to bag RBS chairman Sir ... 08-Aug-2014 Telegraph
Sir Philip Hampton may quit RBS in potential mov... 08-Aug-2014 Guardian
GlaxoSmithKline affirms policy of anti-corruptio... 24-Jul-2014 Guardian
Pained Glaxo sees sales take turn for the worse 24-Jul-2014 Express & Star

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,308.50p
Change Today 8.50p
% Change 0.65 %
52 Week High 1,812.50p
52 Week Low 1,300.00p
Volume 3,969,966
Shares Issued 4,145.10m
Market Cap £54,239m
Beta 0.56
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.16% below the market average48.16% below the market average48.16% below the market average48.16% below the market average48.16% below the market average
16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average
Price Trend
36.75% below the market average36.75% below the market average36.75% below the market average36.75% below the market average36.75% below the market average
18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average18.37% above the sector average
Income
47.15% above the market average47.15% above the market average47.15% above the market average47.15% above the market average47.15% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
5.4% below the market average5.4% below the market average5.4% below the market average5.4% below the market average5.4% below the market average
23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average23.53% above the sector average

What The Brokers Say

Strong Buy 7
Buy 4
Neutral 11
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 15-Nov-24 15-Aug-24
Paid 09-Jan-25 10-Oct-24
Amount 15.00p 15.00p

Trades for 21-Nov-2024

Time Volume / Share Price
16:13 51 @ 1,308.56p
16:13 4,660 @ 1,308.50p
16:13 954 @ 1,308.50p
16:13 182 @ 1,308.50p
16:13 454 @ 1,308.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page